Document is current

Any future updates will be listed below

Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin

Crossref DOI link: https://doi.org/10.1007/s10585-015-9734-1

Published Online: 2015-07-17

Published Print: 2015-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark